Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance,…
Events & Webinars, Hot Topics, Latest News,
Australia’s TGA CPPs Open Doors to Global Pharmaceutical Markets
TGA Certificates of Pharmaceutical Products (CPPs) are a trusted tool for supporting international medicine registrations, offering regulatory credibility and flexibility across a wide range of global…
Events & Webinars, Hot Topics, Latest News,
Medical Information in the Post-Pandemic Era: Embracing Change for the Future
The COVID-19 pandemic catapulted Medical Information (MI) into a new era, fast-tracking digital innovation and redefining how we engage and support healthcare professionals in a rapidly evolving…
Events & Webinars, Hot Topics, Latest News,
Turning Medical Information into Actionable and Accessible Insights
Why the answers we need are already in our inboxes, phone calls, and reports, if we know how to look….
Events & Webinars, Hot Topics, Latest News,
Australia as a Strategic Gateway for Pharmacovigilance Leadership in APAC: Reflections from the ARCS Conference 2025
Explore how Australia’s people, partnerships, and regulatory strength position it as a leader in pharmacovigilance across the Asia-Pacific…
Are You Really Meeting Your Quality Management Obligations?
As a sponsor, supplier or distributor of medicines or medical devices, you must understand your obligations to establish and maintain a fit for purpose Quality Management System (QMS)….
Cyclone Alfred: A Wake-Up Call to Strengthen Temperature Excursion Protocols and Elevate Medical Information Services
A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic…
Commercial Eyes is backing Australia’s digital health vision through its partnership with ANDHealth
A strategic step forward for Australia’s digital and connected health sector. At Commercial Eyes, we believe in the power of collaboration. Today, we are proud to announce a strategic…
Navigating Turbulent Waters: Overcoming Challenges with TGA GMP Clearance Timelines
TGA GMP clearance delays are challenging sponsors in Australia. Discover key issues affecting product registrations and supply and explore strategies to navigate these…
Events & Webinars, Latest News,
PV Summit 2025 Recap: Are You Inspection-Ready?
The ARCS PV Summit 2025 reinforced the critical importance of inspection readiness and sponsor accountability across all product types with the TGA signaling a strategic focus on listed…
Celebrating Our EcoVadis Silver Medal
Our ongoing commitment to sustainability and ethical practices has led us to achieve the EcoVadis Silver rating after only our second year! This milestone reflects our dedication to continuous improvement…
Health innovation trends for 2025: The era of personalisation, precision, and patient empowerment
As health innovation continues to accelerate, 2025 will be another transformative year, driven by several major trends that combine and overlap technology, personalisation, and sustainability. Based on everything we have learned…
Season’s Greetings from Commercial Eyes!
We wish you and your loved ones a holiday filled with peace, joy, and cherished moments – and a New Year that brings health, happiness, and…
Understanding Risk Management Programs: Ensuring Patient Safety, Regulatory Compliance, and Optimized Therapy
Part 5 of 6: A poorly implemented Risk Management Program (RMP) can erode trust, increase risks, and jeopardise outcomes. Learn how thoughtful design and technology can enhance patient safety, regulatory…
Understanding the unique value proposition and buyer segmentation to develop investor ready research for a global hardware and SaMD company
Commercial Eyes’ client, Vitrafy has successfully completed their initial public offering (IPO) on the Australian Securities Exchange (ASX). We unpack the work Commercial Eyes delivered to inform and support the development…
At Commercial Eyes, we’re united in the fight against breast cancer—a cause close to our hearts
This year, our team came together for a special Breast Cancer Awareness Bake-off to honor survivors, foster community, and raise funds for research and patient care. With nearly 21,000 Australians…
ProductLife Group Highlights the Key Role of Artificial Intelligence (AI) in Transforming the Life Sciences Industry
Explore ProductLife Group’s latest insights on the transformative impact of AI in life sciences. From drug discovery to pharmacovigilance, learn how AI is shaping a smarter future for pharma. With…
Making the Right Call: Commercial Eyes’ Expertise in Assessing In-Licensing Opportunities
At Commercial Eyes, we empower our clients to make informed, confident decisions about whether to license a product by offering comprehensive, data-driven assessments that balance clinical promise with commercial viability….
Delivering Critical Therapies to Patients in Need through Managed Access Programs? Expert execution makes all the difference.
Outsourcing Managed Access Programs (MAPs) to specialised partners like Commercial Eyes offers pharmaceutical companies the significant advantage of freeing up internal staff time while ensuring ongoing compliance and…
Empowering Patients with Comprehensive Support: How Commercial Eyes’ Patient Support Programs Make a Difference
In part three of our six-part series, we focus on how the right design of Patient Support Programs (PSPs) empowers patients and improves outcomes in their treatment journey. At Commercial…
Unlocking Patient Access and HCP experience
In part two of our six-part series, we dive deeper into Access Programs, which, at their heart, play a pivotal role in bringing innovative treatments to patients prior to launch….